334 related articles for article (PubMed ID: 18575746)
1. Cadherin-11-mediated interactions with bone marrow stromal/osteoblastic cells support selective colonization of breast cancer cells in bone.
Tamura D; Hiraga T; Myoui A; Yoshikawa H; Yoneda T
Int J Oncol; 2008 Jul; 33(1):17-24. PubMed ID: 18575746
[TBL] [Abstract][Full Text] [Related]
2. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T
Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180
[TBL] [Abstract][Full Text] [Related]
3. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro.
Yoneda T; Williams PJ; Hiraga T; Niewolna M; Nishimura R
J Bone Miner Res; 2001 Aug; 16(8):1486-95. PubMed ID: 11499871
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the glycosylation profile of the human breast cancer cell line, MDA-231, and a bone colonizing variant.
Carcel-Trullols J; Stanley JS; Saha R; Shaaf S; Bendre MS; Monzavi-Karbassi B; Suva LJ; Kieber-Emmons T
Int J Oncol; 2006 May; 28(5):1173-83. PubMed ID: 16596233
[TBL] [Abstract][Full Text] [Related]
5. TNF-alpha and IL-1beta suppress N-cadherin expression in MC3T3-E1 cells.
Tsutsumimoto T; Kawasaki S; Ebara S; Takaoka K
J Bone Miner Res; 1999 Oct; 14(10):1751-60. PubMed ID: 10491223
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.
Hiraga T; Kizaka-Kondoh S; Hirota K; Hiraoka M; Yoneda T
Cancer Res; 2007 May; 67(9):4157-63. PubMed ID: 17483326
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer.
Hiraga T; Myoui A; Choi ME; Yoshikawa H; Yoneda T
Cancer Res; 2006 Feb; 66(4):2067-73. PubMed ID: 16489006
[TBL] [Abstract][Full Text] [Related]
8. Osteoprotegrin and the bone homing and colonization potential of breast cancer cells.
Kapoor P; Suva LJ; Welch DR; Donahue HJ
J Cell Biochem; 2008 Jan; 103(1):30-41. PubMed ID: 17471510
[TBL] [Abstract][Full Text] [Related]
9. Involvement of IL-8 in COX-2-mediated bone metastases from breast cancer.
Singh B; Berry JA; Vincent LE; Lucci A
J Surg Res; 2006 Jul; 134(1):44-51. PubMed ID: 16678856
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of osteoblastic metastases: role of endothelin-1.
Mohammad KS; Guise TA
Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S67-74. PubMed ID: 14600594
[TBL] [Abstract][Full Text] [Related]
11. ALCAM, activated leukocyte cell adhesion molecule, influences the aggressive nature of breast cancer cells, a potential connection to bone metastasis.
Davies S; Jiang WG
Anticancer Res; 2010 Apr; 30(4):1163-8. PubMed ID: 20530423
[TBL] [Abstract][Full Text] [Related]
12. Tumor alphavbeta3 integrin is a therapeutic target for breast cancer bone metastases.
Zhao Y; Bachelier R; Treilleux I; Pujuguet P; Peyruchaud O; Baron R; Clément-Lacroix P; Clézardin P
Cancer Res; 2007 Jun; 67(12):5821-30. PubMed ID: 17575150
[TBL] [Abstract][Full Text] [Related]
13. Transcriptome analysis reveals an osteoblast-like phenotype for human osteotropic breast cancer cells.
Bellahcène A; Bachelier R; Detry C; Lidereau R; Clézardin P; Castronovo V
Breast Cancer Res Treat; 2007 Jan; 101(2):135-48. PubMed ID: 17028989
[TBL] [Abstract][Full Text] [Related]
14. Human bone marrow stromal cells enhance breast cancer cell growth rates in a cell line-dependent manner when evaluated in 3D tumor environments.
Sasser AK; Mundy BL; Smith KM; Studebaker AW; Axel AE; Haidet AM; Fernandez SA; Hall BM
Cancer Lett; 2007 Sep; 254(2):255-64. PubMed ID: 17467167
[TBL] [Abstract][Full Text] [Related]
15. Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases.
Kelly T; Suva LJ; Huang Y; Macleod V; Miao HQ; Walker RC; Sanderson RD
Cancer Res; 2005 Jul; 65(13):5778-84. PubMed ID: 15994953
[TBL] [Abstract][Full Text] [Related]
16. Dynamic interaction between breast cancer cells and osteoblastic tissue: comparison of two- and three-dimensional cultures.
Krishnan V; Shuman LA; Sosnoski DM; Dhurjati R; Vogler EA; Mastro AM
J Cell Physiol; 2011 Aug; 226(8):2150-8. PubMed ID: 21520067
[TBL] [Abstract][Full Text] [Related]
17. N-cadherin engagement provides a dominant stop signal for the migration of MDA-MB-468 breast carcinoma cells.
Potthoff S; Entschladen F; Niggemann B; Zaenker KS; Lang K
Breast Cancer Res Treat; 2007 Nov; 105(3):287-95. PubMed ID: 17171299
[TBL] [Abstract][Full Text] [Related]
18. Fidelity of Runx2 activity in breast cancer cells is required for the generation of metastases-associated osteolytic disease.
Barnes GL; Hebert KE; Kamal M; Javed A; Einhorn TA; Lian JB; Stein GS; Gerstenfeld LC
Cancer Res; 2004 Jul; 64(13):4506-13. PubMed ID: 15231660
[TBL] [Abstract][Full Text] [Related]
19. Cortactin potentiates bone metastasis of breast cancer cells.
Li Y; Tondravi M; Liu J; Smith E; Haudenschild CC; Kaczmarek M; Zhan X
Cancer Res; 2001 Sep; 61(18):6906-11. PubMed ID: 11559568
[TBL] [Abstract][Full Text] [Related]
20. Diversity of cell-mediated adhesions in breast cancer spheroids.
Ivascu A; Kubbies M
Int J Oncol; 2007 Dec; 31(6):1403-13. PubMed ID: 17982667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
